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ANTIMICROBIAL ACTIVITY AND PHYTOCHEMICAL STUDY OF VERNONIA GLABRA 











Infectious diseases are prevalent and life threatening in Kenya. Majority of the sick are seeking herbal remedies in 
search of effective, safe, and affordable cure. This project aims to investigate the antimicrobial activity and presence of 
active phytochemical compounds in different parts of Vernonia glabra; a plant used by herbalists in various regions of 
Kenya, for the treatment of gastrointestinal problems. The plant sample was collected in January 2010 in Machakos, and 
different parts dried at room temperature under shade, ground into powder and extracted in Dichloromethane: Methanol in 
the ratio 1:1, and water. These crude extracts were tested against Staphylococcus aureus, Escherichia coli, Candida albicans, 
and Aspergillus niger for antimicrobial activity using disc diffusion technique. Minimum inhibitory concentrations (MICs) 
for active crude extracts were done using disc diffusion technique after the failure of agar and broth dilution methods. It was 
observed that the organic crude extracts of flower, leaf, stem, root, and/or entire plant, showed activity against at least one of 
the four micro-organisms screened, and at concentrations lower than the aqueous crude extracts. Organic crude extract of the 
leaf showed the highest activity against Staphylococcus aureus (mean inhibition zone of 1.85), recording higher activity than 
the commercially used standard antibiotic (Streptomycin mean inhibition zone of 1.30). The organic crude extract of flower 
showed significant activity only against S. aureus, with the lowest MIC of 1.5625 mg/100µl, compared to streptomycin with 
M.I.C of 6.25 mg/100µl. Thin Layer Chromatography-Bioautography Agar-Overlay showed that, flower alkaloids (50% 
active), root sapogenins (43.8% active), and root terpenoids (38.5% active) were identified as the potential antibacterial 
compounds against S. aureus. These results suggest that, V. glabra contains phytochemicals of medicinal properties and 
justify the use of V. glabra in traditional herbal medicine for the treatment of microbial based diseases. However, research 
on toxicity which is missing in this study is recommended for V. glabra in order to verify, validate and document the safety 
of this medicinal plant to the society. 
 





Infectious diseases caused by microbes are a major health hazards all over the world, Jigna et al., (2007); 
Sasikumar et al., (2007). Throughout history, infectious diseases have been a major threat to human and animal health and a 
prominent cause of morbidity and mortality, WHO/FAO/OIE, (2003). The use of natural products with therapeutic 
properties is as ancient as human civilization and for a long time, mineral, plant and animal products were the main source of 
drugs. For centuries, people have used plants for healing, Maryam et al., (2010). About 80% of the worlds people rely on 
traditional plant based medicine, UNEP, (2010).  Increased antibiotic resistance has become a global concern, coupled with 
the problem of microbial persistence, thus highlighting the need to develop novel  microbial drugs that are not only active 
against drug resistant microbes, but more importantly, kill persistent micro-organisms and shorten the length of treatment. 
Apart from toxicity, lengthy therapy also creates poor patient compliance, Mariita et al., (2010). It is estimated that about 
75% population in Kenya seeks health care among traditional healers, Sandiga et al., (1995).  Traditional medicine is widely 
practiced in Kenya, where this has been documented by ethnomedical surveys, Miaron et al., (2004); Kareru et al., (2007). 
  The high cost of important conventional drugs and/ or inaccessibility to western health care facilities has led to overreliance 
on traditional medicine since it is affordable and available to people. On the other hand, even when western health facilities 
are available, traditional medicine is viewed as an efficient and an acceptable system from a cultural perspective, Munguti, 
(1997). Infections associated with bacterial and fungal pathogens are among some of the indications treated using traditional 
remedies in Kenya. Therefore, the aim of this project is to investigate the efficacy and phytochemical compounds present 
and active in different parts of V. glabra; an herb used by traditional practitioners in Kenya. A decoction of leaf plus root 
taken orally is claimed to treat gastrointestinal problems in Kenya Johns et al., (1995). The leaf ash or crushed leaves rubbed 
into scarification around the snake bite is used as antidote, Owour and Kisangau, (2006). 
 
 
Material and Methods 
Collection of Plant Material 
 
The plant was selected based on ethnomedicinal information from literature and collected from Kathiani village in 
Machakos county, Kenya in January 2010 which falls within the floral region K4 (Fig.1). The specimen was authenticated 
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Crude plant Extracts preparation 
 
The flowers, leaves, stem, and roots were air-dried under the shade at room temperature, ground into powder and 
extracted using Dichloromethane/Methanol in the ratio 1:1, and water, according to standard extraction methods (Harborne, 
1998). 20g of powdered plant material was mixed thoroughly with appropriate amount of solvent, left to stand for 24 hours 
and decanted (this was done twice). The filtrates were combined and filtered using a Buchner funnel. Dry organic crude 
extracts were obtained after evaporating Dichloromethane and Methanol using a rota evaporator.  The aqueous extracts 
filtrates were dried into powder using a freeze drier. These were made up to desired concentrations for antimicrobial assay 
tests. 
 
Sources of Micro-organisms and Preparation of Standard inoculums 
 
Pure cultures of bacteria; Staphylococcus aureus ATCC 259213, Escherichia coli NC 35218 (from School of 
Pharmacy, University of Nairobi) were maintained on nutrient broth slants at 4oC, while fungi; Candida albicans SC 5314 
(from Seattle Biomedical Research Institute U.S.A), and Aspergillus niger ATCC 16404 (a collection of the late Professor 
George M. Siboe, University of Nairobi) were maintained on Sabourauds’ Dextrose agar at 4oC. The standard inoculums 
suspensions were adjusted to turbidity equivalent to 0.5 McFarland standards to give a density of 1x108 cells or spores/ml 
(Nostro et al., 2000). 
 
 





Disc diffusion technique recommended by the National Committee for Clinical Laboratory Standards (NCCLS) 
was used. 2 ml stock solution at concentration 2000 mg/2 ml (1000 mg/ ml) was prepared for each plant part and entire plant 
used.  Two fold serial dilutions were prepared from each stock solution. Paper discs were punched from Whatman filter 
paper No.1 using a paper punch. From each concentration prepared, 100 µl were pipetted onto individually placed sterile 
paper discs (0.6cm) on flat-bottomed glass plates drop by drop using a micropipette.  The paper discs were allowed to dry 
before the release of the next drop, and kept under low temperatures waiting for antimicrobial assays. The potency of each 
paper disc per extract for the concentrations prepared was; 100 mg/100µl, 50 mg/100µl, 25 mg/100µl, 12.5 mg/100µl, 6.25 
mg/100µl, 3.125mg /100µl, 1.5625 mg/100µl, 0.78125 mg/100µl, 0.390625 mg/100µl and 0.1953125 mg/100µl. 
Impregnated paper discs with crude extracts, were aseptically transferred onto plates inoculated with 1ml of standard 
inoculum for each test organism. The plates were labelled, sealed with parafilm, and incubated at 37oC for S. aureus, E. coli, 
C. albicans, and 25oC for A. niger.  Streptomycin (for bacteria) and Nystatin (for fungi) were used as standards at similar 
concentrations, while discs with extraction solvents only were used as controls.  These were done in duplicates under sterile 
conditions. The results were recorded after 24, 48, 72 and 96 hours. The antimicrobial activity was determined by measuring 
clear inhibition zones diameters (including diameter of paper discs) formed using a transparent ruler (in cm). Minimum 
inhibitory concentrations (MICs) were determined by recording the lowest concentration of the active extracts that inhibited 
growth of the micro-organisms (Ochei and Kolhatkar, 2000). 
 
Chemical Analysis of Selected Crude plant Extracts 
 
Extracts that exhibited MICs of ≤25 mg/100µl) against any of the test-organisms used were selected for chemical 
analysis. They were screened for the presence or absence of five classes of compounds namely: alkaloids, Sapogenins, 
terpenoids, quinones, and flavonoids using Thin Layer Chromatography (TLC) technique. The developed TLC plates were 
viewed under Ultra-Violet light and then sprayed with appropriate reagents for the detection of the chemical groups 
according to Harborne (1998). 
 
Bioautography Agar Over-Lay 
 
The active compounds were identified using bioautography agar over-lay method on commercially prepared 
Aluminium silica gel TLC plates against only the most affected test-organism. The separated spots were observed under UV 
lamp and the freshly prepared standard inoculum of Staphylococcus aureus in nutrient agar was uniformly overlaid on the 
TLC plates with the crude extracts and incubated at 37oC for 24 hours, then sprayed with aqueous solution of 2.5 mg/ml 
thiazolyl blue (3-(4, 5 dimethylthiazolyl-2-2, 5-diphenyl tetrazolium bromide (MTT), Nostro et al., (2000); Runyoro et al., 




In order to analyse data, multiple way ANOVA was used to determine significant factors in formation of inhibition 
zones, Tukey’s Honest Significant Difference Test (THSDT) was used for means comparison within the significant factors. 
Ms Word 2007 was used to draw tables; Ms Excel 2007 was used to determine means inhibition zones, percentage number 




The antimicrobial activity. 
 
The antimicrobial activity (formation of inhibition zones) of Vernonia glabra crude extracts depended on: (a) parts 
of plant used, (b) extraction solvent, and (c) test-organism factors (Table 1). 
 
Table 1: Significance of Parts of plant used, Extraction solvent, and Test-organism  in production of Inhibition zones 
                                          Df         Sum Sq        Mean Sq        F value             Pr(>F)     
Extraction Solvent           1             5.610           5.6103            89.1855           < 2.2e-16 *** 
 Parts of plant used          4             1.985           0.4963            7.8902             2.612e-06 *** 
Test-organism                  3             11.268         3.7560            59.7081           < 2.2e-16  *** 
Time                                 3             0.066           0.0220            0.3492             0.7898     
Residuals                        2068       130.089        0.0629                       
--- 
Signif. codes:      0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
*Based on multiple-way ANOVA , part of plant used, test- organism, and extraction solvent  factors were significant, but the 
time factor was not significant at statistical p-value≤0.05 
 
Three factors namely: extraction solvent, parts of plant used, and test-organism were highly significant in the production of 
inhibition zones at p-value=0.00*** (0% error); less than the accepted statistical p-value≤0.05 (5% error) in this study (see 
Table 1). The time factor (incubation period) was insignificant in that it has p-value=0.7898, greater than the accepted p-
value≤0.05 (5% error) and therefore it was rejected.  
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(a)Parts of plant used: In this study, mean inhibition zones were used as the results for figures 2, 3 and 4 below. All the 
organic crude extracts of V. glabra parts used were active on at least one of the four test-organisms used (see Fig. 2). It was 
observed that organic extracts of V. glabra leaf had the highest activity (inhibition zone of 1.85) against S. aureus, followed 
by organic extract of flower with inhibition zone of 1.78 against only S. aureus. The two extracts showed no significant 
difference in activity from each other, but were significantly different in activity from streptomycin (inhibition zone of 1.30).  
Also organic extract of leaf recorded high activity (inhibition zone of 1.43) against A. niger, compared to nystatin  
(inhibition zone of 0.83), while the organic extract of whole plant (all parts mixed) showed significant activity (inhibition 




Figure 2: Antimicrobial activity of organic crude extracts of V. glabra parts compared to streptomycin and nystatin at 100 
mg/100 µl 
 
Note: CH2Cl2:CH3OH- Dichloromethane and Methanol in the ratio 1:1(negative Control). 
Aqueous extract of the whole plant of V. glabra was the only active aqueous extract against S. aureus (see Fig.3).  
 
Figure 3: Antimicrobial activity of aqueous crude extracts of V. glabra parts compared to streptomycin and nystatin at 100 
mg/100 µl 
The controls (Dichloromethane: Methanol 1:1, and sterile distilled water) were not active against any test-organism  
Note: H2O: Sterile distilled water (negative control). 
 
(b) Extraction Solvent: The organic extracts of V. glabra were generally more active than the aqueous extracts most of 
which had lower activity or no activity against at least one of the four micro-organisms tested (Figure 4).  




Figure 4: Organic versus aqueous crude extracts of V. glabra compared to streptomycin and nystatin at 100 mg/100 µl 
 
(c).Test-organism: S. aureus was the most susceptible to organic extracts (inhibition of 0.35) and was significantly different 
in susceptibility from A. niger, C. albicans, and E. coli  which had inhibition zones of 0.05, 0.03, and 0.01 respectively (see 
Fig. 4).  
 
Minimum inhibitory concentration: MIC of each extract that was able to kill or inhibit the growth of at least one of the 
four micro-organisms tested in this study was exhibited by extracts that were active at concentration of 100 mg/100 µl to 
0.02 mg/100 µl. The lowest MICs (1.5625-0.02 mg/100 µl) indicate highest activity, while 6.25-3.125 mg/100 µl (moderate 
activity), and 12.5-100 mg/100 µl indicate low activity (Table 2). 
 
 
Table 2: MICs (mg/100µl) and Inverse of MICs (mg/100 µl) of organic and aqueous extracts of V. glabra/Antibiotics 
against S. aureus, E.coli, A. niger, and C. albicans. 
Extract/Antibiotic Test-organism MICs of 
Extracts/Antibiotics 
(mg/100 µl) 
Inverse of MICs 
(mg/100 µl) 
Remarks 
Organic extracts     
Flower S.aureus 1.5625 0.64 High activity 
E. coli 0.02+1 0.98 High activity Streptomycin (Antibiotic) 
S. aureus 6.25 0.16 Moderate activity 
A. niger 3.125 0.32 Moderate activity Nystatin (Antibiotic) 
C. albicans 3.125 0.32 Moderate activity 
S. aureus 12.5 0.08 Low active 
E. coli 100 0.01 Low  active 
Leaf  
A. niger 25 0.04 Low active 
Stem A. niger 100 0.01 Low  active 
S. aureus 25 0.04 Low active Root 
C. albicans 50 0.02 Low active 
Whole plant S. aureus 25 0.04 Low active 
Aqueous extract     
Whole plant S. aureus 100 0.01 Low active 
 
Note*: 0.02+1- 1 was added to 0.02 in order to get a value that will minimize the big range among the inverse numbers, 
because values without whole numbers tend to have high inverse numbers. 
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The inverse of MICs was displayed on fig. 5 below. Organic extract of flower showed highest activity recording the lowest 
MIC of 1.5625mg/100µl against S. aureus, which was lower than the standard antibiotic (streptomycin) with MIC of 
6.25mg/100µl. The organic extracts of root, whole plant against S. aureus, and leaf against A. niger and S. aureus had low 
activity (Fig. 5). The organic extract of root against C. albicans, organic extract of whole plant against A. niger, organic 
extract of stem against A. niger, and aqueous extract of whole plant against S. aureus, and organic extract of leaf against E. 
coli were less effective at higher concentrations (Figure 5). 
 
 Figure 5: MICs for organic and aqueous extracts of V. glabra compared to streptomycin and nystatin (antibiotics). 
 
Note: Extracts/antibiotics with high inverse of MICs indicate higher activity (MIC 0.64-0.98 mg/100 µl) at low 
concentrations, extracts/antibiotics with inverse of MICs of 0.16-0.32 mg/100 µl indicate moderate activity, while the 
extracts with low inverse of MICs display low activity at higher concentrations (see Table 2). 
  
Presence and Activity of Chemical Compounds.  Out of all the alkaloids screened present in different parts, flower 
alkaloids were 50% present and all were active against S. aureus. Root sapogenins made up 43.8% of all sapogenins present 
and all were active, while flower sapogenins followed with 31.3% presence and all were active against S. aureus. Root 
terpenoids showed 38.8% presence out of all terpenoids and almost all of them (38.5%) were active against S. aureus. 
Quinones of flower and leaf accounted for 37.5% presence, but only leaf quinones were moderately active at 25% activity, 
where as flower qiunones were less active at 12.5%. Flower flavonoids were present at 36.4%, while both leaf and root 
flavonoids showed 31.8% presence out of all flavonoids screened and found present in different parts, but all showed less 
activity of 9.1% against S. aureus (Figure 6).   
 
Figure 6: Percentage number of five classes of compounds present and active in V.glabra crude extracts (flower, leaf, and 
root). 
Note*: Most of the alkaloids and sapogenins present in the different parts, and root terpenoids were active against S. aureus.  
Leaf quinones were moderately active, while all flavonoids in all different parts were less active. (fig.6). 





The organic extracts of leaf (1.85) and flower (1.78) against S. aureus, had larger inhibition zones than the 
standard antibiotic (streptomycin 1.30). These results suggest that, these extracts could be used for management of bacterial 
diseases caused by Staphylococcus aureus such as boils, sores and wounds.  The organic extract of leaf (1.43 against A. 
niger) showed high activity compared to nystatin (inhibition zone of 0.83). This signifies that, this extract could be used to 
produce novel antifungal compounds, for management of Aspergillosis disease caused by Aspergillus niger.  
 These results validate the use of V. glabra by traditional medicine practitioners in Kenya. The findings of this study are in 
agreement with the studies of Chika et al., 2007 who reported large inhibition zones of organic extracts of Euphorbia hirta 
leaf, against S. aureus, and justified its use by traditional medicinal practitioners for treatment of boils, sores and open 
wounds. Literature study done on V. glabra, elicited no previous research work on the antimicrobial activity of crude 
extracts of leaf and flower. As such, this could be the first report on such activity and could very well be a start point for 
further drug research of this species on a wide diversity of microbial pathogens.  
Organic extracts of leaf against E. coli and root against S. aureus were less active compared to streptomycin, as well as 
extract of root against C. albicans and stem against A. niger compared to nystatin respectively. These findings could suggest 
presence of resistance of these test-organisms, and could be more active if the concentration of the extracts is increased. 
These findings are supported by Ochei and Kolhatkar, (2006) who reported that if drugs show less activity against micro-
organisms it is an indication of development of resistance by the test-organisms and that increase in drug concentration 
would increase the antimicrobial activity. 
  However, some of the crude extracts were not active against any of the four micro-organisms tested. For instance, 
organic extracts of flower (Fig.2) was not active against E. coli, A. niger, and C. albicans, while extract of stem was not 
active against S. aureus, E. coli, and C. albicans and no activity was exhibited by leaf extract against C. albicans 
respectively. These ineffective extracts, could have antimicrobial compounds active against diverse microbial pathogens that 
have not been worked on in this study. These findings correlate with the previous studies of Johns et al., 1995 who reported 
that decoction of V. glabra leaf and root was active against a non bacterial or non fungal micro-organism; Giardia lambria 
which is a protozoan.  
 Moreover, this study shows that there are synergistic, intermediate, and antagonistic effects among the plant parts 
used and their mixture. The organic extract of whole plant mixed (inhibition zone of 1.50 against S. aureus), showed 
intermediate activity ranging in between its highly active and less active single parts, yet traditional medicine prefer mixing 
(combining). This study may be an eye open for traditional medicine, and could indicate that, the interactions of active 
chemical substances present in single crude extracts of plant parts used, have strong synergistic effects to inhibit the growth 
of test-organisms, compared to their mixture with intermediate effect. This result could be due to antagonising effects of less 
active or inactive extracts, lessening the effect of highly active single crude extracts of V. glabra. These findings are in line 
with the findings of Maryam et al., (2010) who did research on different plant parts and mixtures (combinations) of plant 
extracts and found that, plant extracts or phytocompounds exhibiting strong antimicrobial activity may interact with each 
other and the interactions may be synergistic or antagonistic. Therefore, the synergistic effects of V. glabra leaf and flower 
extracts in this study would be of significant importance in further search of novel drugs, with desirable synergistic effects, 
to kill persistent micro-organisms that are resistant to known antibiotics and probably delay emergency of microbial 
resistance. 
The organic extracts were active against S. aureus, A. niger, C. albicans, and E. coli with Mean inhibition zones of 
0.35, 0.05, 0.03 and 0.01 respectively. The aqueous extracts were less active against S. aureus only (Mean inhibition zone of 
0.02) and inactive against E. coli, A. niger, and C. albicans. Noting that the traditional herbal remedy preparation from this 
species is by use of water, it is a paradox that the aqueous extracts were inactive in this study. This may be due to the 
absence or insufficient and effective concentration of the antimicrobial constituents in the aqueous extracts of V. glabra. 
These findings are in agreement with the studies of Koua et al., (2011) who reported that inactivity of aqueous and organic 
extracts of Striga hermonthica may be due to absence or insufficient and effective concentration of the antimicrobial agents 
of S. hermonthica extracts. It is well known that patients using the traditional herbs take in large amounts of the concoctions 
and hence may eventually consume sufficient amounts of the curative drugs to elicit healing. 
Differential sensitivity of bacteria to V. glabra extracts may be explained by the cell wall composition of the gram-
positive and gram-negative bacteria. The cell wall of gram-ve bacteria (E. coli), contains the outer membrane and lipid 
bilayer embedded with proteins and porins that determine and allow different molecules or ions either into or out of the cell 
and thus the outer membrane serves as a barrier to the passage of many molecules and hence less sensitive to many extracts 
and render E. coli resistant to plant extracts. The gram+ve bacterium (S. aureus) has a relatively thick layer of peptidoglycan 
sheets of interconnected glycan chains made up of polymer which is fully permeable to many substances, and thus sensitive 
to most extracts, Nester et al., (2004).   
Less effects of the crude extracts against C. albicans (yeast fungus) compared to A. niger (filamentous fungus) 
may also be due to differences in cell wall composition of the organisms. Yeast fungus cell wall contains polysaccharides 
and proteins, compared to chitin and glycan found in the cell walls of filamentous fungi, Paiva et al., (2010). The protein 
expression on C. albicans, function as selective transport system used to expel wastes and compounds that are otherwise 
deleterious to the cell; a function called efflux which is medically important in that, it allows micro-organisms to oust 
antimicrobial medications that are made to destroy them and therefore render them resistance, Nester et al., (2004). This 
explanation could be one of the reasons why C. albicans was resistant to most crude extracts. This observation reported in 
this study is in agreement with the findings of Masakazu et al., (2010), who did research on antifungal drug resistance of 
Candida spp and reported that expression of drug efflux pumps were responsible for the resistance. 
The higher activity of organic extract of flower compared to the standard antibiotic (streptomycin) is significant. 
Such comparisons may be used as yardstick to identify novel drugs with new mechanisms of action to combat bacterial 
strains resistant to known antibiotics, shorten the length of treatment, increase patient compliance, and avoid overdose which 
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may lead to toxicity or side effects to patients. The findings of this study are in line with the studies of Mariita et al., (2010); 
Aiyegoro and Okoth, (2009), who reported that bioactive extracts of medicinal plants at low concentrations are not only 
active against drug resistant bacteria, but kill persistent bacteria, shorten the length of treatment, reduce overdose and 
toxicity or side-effects. 
The higher antimicrobial activity of Vernonia glabra flowers could be attributed to the presence of large amounts 
of flower alkaloids 50% (Fig. 6). Alkaloids are pharmacogenically active basic principles of flowering plants, Das et al., 
(2010). The observed activity of these compounds in V. glabra is in line with that of Sawer et al., (2005) (as cited in Karou 
et al., 2006) who demonstrated that the Indoloquinoline alkaloid causes cell lysis and morphological changes of S. aureus. 
The presence of alkaloids in V. glabra extracts has not been reported in any previous research work and the findings in this 
study could be the first one to report.  Root sapogenins (43.8% present and active) have been associated with hemolysis 
property and it’s probably why significant anti-staphylococcal activity has been reported in this study. This finding is in 
agreement with the studies of Pinarosa, et al., (2006) who did research on sapogenins of Medicago arabica root and reported 
a high anti-staphylococcal activity against S. aureus. According to literature on V. glabra sapogenins, no previous work has 
reported the presence of sapogenins in V. glabra. This could be the first time to report.  
The antibacterial activity of root terpenoids (38.5% active) may be due to presence of terpenes combined and 
associated with bacterial membrane disruption. This finding is in line with the studies of Chiruvella et al., (2007) who did 
research on terpenoids isolated from callus cultures of soymida febrifuga and reported that antimicrobial activity of 
terpenoids is probably due to membrane disruption by the terpenes. On the other hand, leaf quinones (37.5% present but 





The screening of ten crude extracts (5 organic and 5 aqueous) of V. glabra collected using available ethnomedical 
information, has justified the medicinal potency in V. glabra used by traditional practitioners in Kenya to treat 
gastrointestinal problems and other different diseases.  The ethnomedicinal information is important and can be used as a 
start point for research in drug development. The high activity of V. glabra flower  reported at lowest MIC of 1.5625 mg/100 
µl than the standard antibiotic (streptomycin MIC of 6.25 mg/100 µl), is significant in treatment of resistant microbial 
pathogens. The low concentrations needed for treatment means that cases of overdose, toxicity, and side-effects may be 
reduced when using V. glabra flowers. However, research on toxicology which is missing in this study is recommended for 
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